Stocks and Investing
Stocks and Investing
Fri, November 18, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Zachary Fadem Maintained (WOOF) at Buy with Decreased Target to $14 on, Nov 18th, 2022
Zachary Fadem of Wells Fargo, Maintained "Petco Health and Wellness Company, Inc." (WOOF) at Buy with Decreased Target from $19 to $14 on, Nov 18th, 2022.
Zachary has made no other calls on WOOF in the last 4 months.
There are 5 other peers that have a rating on WOOF. Out of the 5 peers that are also analyzing WOOF, 2 agree with Zachary's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Oliver Wintermantel of "Evercore ISI Group" Downgraded from Buy to Hold and Decreased Target to $12 on, Wednesday, October 19th, 2022
- Simeon Gutman of "Morgan Stanley" Maintained at Hold with Decreased Target to $19 on, Thursday, August 25th, 2022
These are the ratings of the 3 analyists that currently disagree with Zachary
- Kate McShane of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $18 on, Tuesday, October 4th, 2022
- Steven Shemesh of "RBC Capital" Initiated at Buy and Held Target at $17 on, Wednesday, September 7th, 2022
- Seth Basham of "Wedbush" Maintained at Buy with Decreased Target to $18 on, Tuesday, July 26th, 2022
Contributing Sources